← Back

Wire · opportunities

FDA clears next-gen peripheral thrombectomy device

Published

13 August 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at cardiovascularbusiness.com

Verified

Fusion42 · 13 August 2026 · Fusion42 review

Vesalio has received FDA clearance for its next-generation peripheral mechanical thrombectomy device, the pVasc NET, featuring a dual-layer distal filter for improved emboli capture during minimally invasive procedures in peripheral blood vessels.

This Wire brief sits within Fusion42's coverage of Medtech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.

◆ The Wire takeaway

You can now position your medtech startup to incorporate or compete with more sophisticated thrombectomy tech in peripheral vascular care as FDA clearance lowers barriers for innovative devices like Vesalio’s pVasc NET.

Related on Wire

Topics

Medtechfda-clearancemedical-devicethrombectomyperipheral-vascularmedtech